4.2 Article

A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls

期刊

ARTHRITIS RESEARCH & THERAPY
卷 18, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s13075-016-0982-5

关键词

Rheumatoid arthritis; Inflammation; Biomarker; Metabolic syndrome; Glycosylation

资金

  1. National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [K23AR054904]
  2. NIH/NIA [P30AG028716]
  3. American College of Rheumatology Research and Education Foundation (ACR-REF/ASP) Junior Career Development Award in Geriatric Medicine funded via Atlantic Philanthropies
  4. John A. Hartford Foundation

向作者/读者索取更多资源

Background: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those for persons without RA. Methods: Plasma GlycA was determined for 50 individuals with mild-moderate RA disease activity and 39 controls matched for age, gender, and body mass index (BMI). Regression analyses were performed to assess relationships between GlycA and important markers of traditional inflammation and cardio-metabolic health: inflammatory cytokines, disease activity, measures of adiposity and insulin resistance. Results: On average, RA activity was low (DAS-28 = 3.0 +/- 1.4). Traditional inflammatory markers, ESR, hsCRP, IL-1 beta, IL-6, IL-18 and TNF-alpha were greater in RA versus controls (P < 0.05 for all). GlycA concentrations were significantly elevated in RA versus controls (P = 0.036). In RA, greater GlycA associated with disease activity (DAS-28; RDAS-28 = 0.5) and inflammation (R-ESR = 0.7, R-hsCRP = 0.7, RIL-6 = 0.3: P < 0.05 for all); in BMI-matched controls, these inflammatory associations were absent or weaker (hsCRP), but GlycA was related to IL-18 (R-hsCRP = 0.3, RIL-18 = 0.4: P < 0.05). In RA, greater GlycA associated with more total abdominal adiposity and less muscle density (Rabdominal-adiposity = 0.3, Rmuscle-density = -0.3, P < 0.05 for both). In BMI-matched controls, GlycA associated with more cardio-metabolic markers: BMI, waist circumference, adiposity measures and insulin resistance (R = 0.3-0.6, P < 0.05 for all). Conclusions: GlycA provides an integrated measure of inflammation with contributions from traditional inflammatory markers and cardio-metabolic sources, dominated by inflammatory markers in persons with RA and cardio-metabolic factors in those without.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据